Arbutus Biopharma Corp Earnings Per Share Diluted

• Arbutus Biopharma Corp showed an increase of +55.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Arbutus Biopharma Corp's annual report (Form 10-K), filed with the SEC on March 23, 2026.
• XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2010 to 2025), Arbutus Biopharma Corp's Earnings Per Share Diluted has grown by 85.8%.
• Historical annual values: Fiscal year 2025: $0.17 (loss) per share | Fiscal year 2024: $0.38 (loss) per share | Fiscal year 2023: $0.44 (loss) per share | Fiscal year 2022: $0.46 (loss) per share | Fiscal year 2021: $0.83 (loss) per share | Fiscal year 2020: $1.00 (loss) per share | Fiscal year 2018: $1.21 (loss) per share | Fiscal year 2017: $1.56 (loss) per share | Fiscal year 2016: $7.24 (loss) per share | Fiscal year 2015: $1.38 (loss) per share | Fiscal year 2014: $1.80 (loss) per share | Fiscal year 2013: $0.92 (loss) per share | Fiscal year 2012: $2.07 per share | Fiscal year 2011: $0.89 (loss) per share | Fiscal year 2010: $1.20 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026